Quince Therapeutics(QNCX) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Cortexyme, Inc. (Exact name of registrant as specified in its Charter) Delaware 90-1024039 (State or other jurisdiction of incorporation or organization) 269 East Grand Ave. South San Francisco, California 94080 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identif ...